Technical Analysis for PVCTW - Provectus Biopharmaceuticals Inc. Warrant

Grade Last Price % Change Price Change
grade F 0.0078 -1.27% -0.0001
PVCTW closed down 1.27 percent on Monday, August 19, 2019, on 1.85 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PVCTW trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -1.27%
Inside Day Range Contraction -1.27%
Wide Bands Range Expansion -1.27%
Oversold Stochastic Weakness -1.27%
MACD Bearish Signal Line Cross Bearish 151.61%
Reversal New Lows Setup Bearish Swing Setup 151.61%

Older signals for PVCTW ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus, please visit the Company's website at www.provectusbio.com or contact Porter, LeVay & Rose, Inc.
Medicine RTT Medical Specialties Organ Systems Immunotherapy Autoimmune Diseases Breast Cancer Fda Psoriasis Atopic Dermatitis Melanoma Biopharmaceuticals Hepatocellular Carcinoma Dermatitis Liver Cancer Metastatic Melanoma Solid Tumor Cancers National Institute Of Health Skin Cancer
Is PVCTW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.089
52 Week Low 0.0005
Average Volume 43,138
200-Day Moving Average 0.015
50-Day Moving Average 0.013
20-Day Moving Average 0.0099
10-Day Moving Average 0.0104
Average True Range 0.0036
ADX 11.22
+DI 27.6074
-DI 39.6728
Chandelier Exit (Long, 3 ATRs ) 0.0082
Chandelier Exit (Short, 3 ATRs ) 0.0139
Upper Bollinger Band 0.0171
Lower Bollinger Band 0.0027
Percent B (%b) 0.35
BandWidth 145.454546
MACD Line -0.0011
MACD Signal Line -0.0007
MACD Histogram -0.0004
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0078
Resistance 3 (R3) 0.0078 0.0078 0.0078
Resistance 2 (R2) 0.0078 0.0078 0.0078 0.0078
Resistance 1 (R1) 0.0078 0.0078 0.0078 0.0078 0.0078
Pivot Point 0.0078 0.0078 0.0078 0.0078 0.0078
Support 1 (S1) 0.0078 0.0078 0.0078 0.0078 0.0078
Support 2 (S2) 0.0078 0.0078 0.0078 0.0078
Support 3 (S3) 0.0078 0.0078 0.0078
Support 4 (S4) 0.0078